Side Effects Related to Cancer Treatment
Authors:
- 20 November 2005
- journal article
- case report
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 23 (33) , 8531-8533
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Bronchioloalveolar Pathologic Subtype and Smoking History Predict Sensitivity to Gefitinib in Advanced Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2004
- Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients With Non–Small Cell Lung CancerJAMA, 2003
- O-240 Clinical experience with gefitinib (‘Iressa’, ZD1839): an overview of safety and tolerabilityLung Cancer, 2003
- Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2003
- Severe acute interstitial pneumonia and gefitinibThe Lancet, 2003